Postoperative ileus (POI) is associated with abdominal pain, nausea, vomiting, and delayed mobilization that in turn lead to diminished patient satisfaction, increased hospital length of stay (LOS), and increased healthcare costs. In this study, the authors developed a risk assessment scale to predict the likelihood of developing POI following spinal surgery.
The authors undertook a retrospective review of a prospectively maintained registry of consecutive patients who underwent arthrodesis/fusion surgeries between May 2013 and December 2017. They extracted clinical information, including cumulative intraoperative and postoperative opioid doses using standardized converted morphine milligram equivalent (MME) values. Univariate and multivariate analyses were performed and several categorical and continuous variables were evaluated in a binary logistic regression model built with backward elimination to assess for independent predictors. A points-based prediction model was developed and validated to determine the risk of POI.
A total of 334 patients who underwent spinal fusion surgeries were included. Fifty-six patients (16.8%) developed POI, more frequently in those who underwent long-segment surgeries compared to short-segment surgeries (33.3% vs 10.4%; p < 0.001). POI was associated with an increased LOS when compared with patients who did not develop POI (8.0 ± 4.5 days vs 4.4 ± 2.4 days; p < 0.01). The incidences of liver disease (16% vs 3.7%; p = 0.01) and substance abuse history (12.0% vs 3.2%; p = 0.04) were higher in POI patients than non-POI patients undergoing short-segment surgeries. While the incidences of preoperative opioid intake (p = 0.23) and cumulative 24-hour (87.7 MME vs 73.2 MME; p = 0.08) and 72-hour (225.6 MME vs 221.4 MME; p = 0.87) postoperative opioid administration were not different, remifentanil (3059.3 µg vs 1821.5 µg; p < 0.01) and overall intraoperative opioid (326.7 MME vs 201.7 MME; p < 0.01) dosing were increased in the POI group. The authors derived a multivariate model based on the 5 most significant factors predictive of POI (number of surgical levels, intraoperative MME, liver disease, age, and history of substance abuse) and calculated relative POI risks using a derived 32-point system.
Intraoperative opioid administration, incorporated in a comprehensive risk assessment scale, represents an early and potentially modifiable predictor of POI. These data indicate that potential preventive strategies, implemented as part of enhanced recovery after surgery protocols, could be instituted in the preoperative phase of care to reduce POI incidence.
ABBREVIATIONSBMI = body mass index; EBL = estimated blood loss; ERAS = enhanced recovery after surgery; GERD = gastroesophageal reflux disease; GI = gastrointestinal; LOS = length of stay; MME = morphine milligram equivalent; MNTX = methylnaltrexone; POI = postoperative ileus; ROC = receiver operating characteristic.
ChapuisPH, BokeyL, KeshavaA, RickardMJ, StewartP, YoungCJ, : Risk factors for prolonged ileus after resection of colorectal cancer: an observational study of 2400 consecutive patients. 257:909–915, 20132357954210.1097/SLA.0b013e318268a693)| false
de HoogdSAhlersSJGMvan DongenEPAvan de GardeEMWDaeterEJDahanA: Randomized controlled trial on the influence of intraoperative remifentanil versus fentanyl on acute and chronic pain after cardiac surgery. Pain Pract18:443–4512018
de HoogdS, AhlersSJGM, van DongenEPA, van de GardeEMW, DaeterEJ, DahanA, : Randomized controlled trial on the influence of intraoperative remifentanil versus fentanyl on acute and chronic pain after cardiac surgery. 18:443–451, 201810.1111/papr.12615)| false
FinebergSJNandyalaSVKurdMFMarquez-LaraANoureldinMSankaranarayananS: Incidence and risk factors for postoperative ileus following anterior, posterior, and circumferential lumbar fusion. Spine J14:1680–16852014
HorowitzJAJainAPuvanesarajahVQureshiRHassanzadehH: Risk factors, additional length of stay, and cost associated with postoperative ileus following anterior lumbar interbody fusion in elderly patients. World Neurosurg115:e185–e1892018
HozumiJEgiMSugitaSSatoT: Dose of intraoperative remifentanil administration is independently associated with increase in the risk of postoperative nausea and vomiting in elective mastectomy under general anesthesia. J Clin Anesth34:227–2312016
HozumiJ, EgiM, SugitaS, SatoT: Dose of intraoperative remifentanil administration is independently associated with increase in the risk of postoperative nausea and vomiting in elective mastectomy under general anesthesia. 34:227–231, 201610.1016/j.jclinane.2016.04.01827687380)| false
KalffJC, SchrautWH, SimmonsRL, BauerAJ: Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. 228:652–663, 199810.1097/00000658-199811000-000049833803)| false
KielyPD, MountLE, DuJY, NguyenJT, WeitzmanG, MemstoudisS, : The incidence and risk factors for post-operative ileus after spinal fusion surgery: a multivariate analysis. 40:1067–1074, 201610.1007/s00264-016-3148-926961191)| false
KimTK, ObaraS, EganTD, MintoCF, La CollaL, DroverDR, : Disposition of remifentanil in obesity: a new pharmacokinetic model incorporating the influence of body mass. 126:1019–1032, 20172850979610.1097/ALN.0000000000001635)| false
KronbergUKiranRPSolimanMSHammelJPGalwayUCoffeyJC: A characterization of factors determining postoperative ileus after laparoscopic colectomy enables the generation of a novel predictive score. Ann Surg253:78–812011
KronbergU, KiranRP, SolimanMS, HammelJP, GalwayU, CoffeyJC, : A characterization of factors determining postoperative ileus after laparoscopic colectomy enables the generation of a novel predictive score. 253:78–81, 20112123360810.1097/SLA.0b013e3181fcb83e)| false
VatherRJosephsonRJaungRRobertsonJBissettI: Development of a risk stratification system for the occurrence of prolonged postoperative ileus after colorectal surgery: a prospective risk factor analysis. Surgery157:764–7732015
VatherR, JosephsonR, JaungR, RobertsonJ, BissettI: Development of a risk stratification system for the occurrence of prolonged postoperative ileus after colorectal surgery: a prospective risk factor analysis. 157:764–773, 201510.1016/j.surg.2014.12.00525724094)| false
YuCSChunHKStamblerNCarpenitoJSchulmanSTzanisE: Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials. Dis Colon Rectum54:570–5782011
YuCS, ChunHK, StamblerN, CarpenitoJ, SchulmanS, TzanisE, : Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials. 54:570–578, 20112147175810.1007/DCR.0b013e3182092bde)| false
YuanCSDoshanHCharneyMRO’ConnorMKarrisonTMaleckarSA: Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans. J Clin Pharmacol45:538–5462005
YuanCS, DoshanH, CharneyMR, O’ConnorM, KarrisonT, MaleckarSA, : Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans. 45:538–546, 20051583177710.1177/0091270004273491)| false
YuanCSFossJFO’ConnorMToledanoARoizenMFMossJ: Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther59:469–4751996